Identification of group B streptococcal sip protein, which elicits cross-protective immunity

Infection and Immunity

Volumn 68, Issue 10, 2000, Pages 5610-5618

  Brodeur, B R ^a   Boyer, M ^a   Charlebois, I ^a   Hamel, J ^a   Couture, F ^a   Rioux, C R ^a   Martin, D ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; DNA; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; IMMUNIZATION; IMMUNOBLOTTING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PURIFICATION; SEROTYPE; STRAIN DIFFERENCE; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODIES; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CLONING, MOLECULAR; CROSS REACTIONS; FEMALE; GENES, BACTERIAL; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; SUPPORT, NON-U.S. GOV'T; VACCINATION; VACCINES, SYNTHETIC;

EID: 0033806081     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.10.5610-5618.2000     Document Type: Article

References (47)

1. Group B streptococcal surface proteins as targets for protective antibodies: Identification of two novel proteins in strains of serotype V
2. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection
3. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus
4. Antibody to group B Streptococcus type III in human sera measured by a mouse protection test
5. The TAT protein export pathway
6. Complete and incomplete Ibc protein fraction in group B streptococci
7. Invasive group B streptococcal disease: The emergence of serotype V
8. PspA, a protection-eliciting pneumococcal protein: Immunogenicity of isolated native PspA in mice
9. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection
10. Surface protein expression in group B streptococcal invasive isolates
11. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA
12. Molecular species of R-protein antigens produced by clinical isolates of group B Streptococci
13. A bacteriophage λ cI857 cassette controls λP(L) expression vectors at physiologic temperature
14. Maternal immunization
15. Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines
16. Techniques for transformation of E. coli
17. Serotype distribution of invasive group B streptococcal isolates in Maryland: Implications for vaccine formulation
18. Differentiation of Streptococcus uberis from Streptococcus parauberis by polymerase chain reaction and restriction fragment length polymorphism analysis of 16S ribosomal RNA
19. Identification of an immunoglobulin A binding motif located in the β-antigen of the c protein complex of group B streptococci
20. Group B streptococcal Ibc protein antigen: Distribution of two determinants in wild-type strains of common serotypes
21. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate Vaccine
22. Cloning and sequence analysis of a gene encoding a 67-kilodalton myosin-cross-reactive antigen of Streptococcus pyogenes reveals its similarity with class II major histocompatibility antigens
23. Characterization of two distinct opsonic and protective epitopes within the alpha C protein of the group B Streptococcus
24. An apparently new strain-variable Streptococcus agalactiae protein
25. Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women
26. Antigens of group B streptococci: Relation to mouse-protective antibodies and immunity
27. Multiple mouse-protective antibodies directed against group B streptococci: Special reference to antibodies effective against protein antigen
28. Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and α
29. Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine
30. Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset systemic infection
31. Phenotypic diversity in the alpha C protein of group B streptococcus
32. Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection
33. Genotypic diversity and evidence for two distinct classes of the C protein alpha antigen of group B Streptococcus
34. C proteins of group B streptococci
35. Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci
36. Proteolytic cleavage and cell wall anchoring at the LPXTG motif of surface proteins in gram-positive bacteria
37. Antigenic and molecular conservation of the gonococcal NspA protein
38. Epidemiology of group B streptococcal disease in the United States: Shifting paradigms
39. Prevention of perinatal group B streptococcal disease: A public health perspective
40. Cloning and sequence analysis of zooA, a Streptococcus zoocepidemicus gene encoding a bacteriocin-like inhibitory substance having a domain structure similar to that of lysostaphin
41. Protein Rib: A novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections
42. Isolation of a C (Ibc) protein from group B Streptococcus which elicits mouse protective antibody
43. Cloning, sequence, and transcriptional regulation of the operon encoding a putative N-acetyl-mannosamine-6-phosphate epimerase (nanE) and sialic acid lyase (nanA) in Clostridium perfringens
44. Identification of a family of streptococcal surface proteins with extremely repetitive structure
45. Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine
46. Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine
47. Type-specific antigens of group B type Ic streptococci